TME Pharma NV
PAR:ALTME
TME Pharma NV
PAR:ALTME
Price:
0.0727
EUR
-0.68%
Market Closed
Market Cap:
€6.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
TME Pharma NV
PAR:ALTME
|
DE |
|
Avex Inc
OTC:AVEXF
|
JP |
|
C
|
Companhia Energetica do Rio Grande do Norte Cosern
BOVESPA:CSRN6
|
BR |
|
A
|
AMEN Properties Inc
OTC:AMEN
|
US |
Income Statement
Earnings Waterfall
TME Pharma NV
TME Pharma NV
Income Statement
TME Pharma NV
TME Pharma NV
Currency: EUR
| Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Interest Expense |
0
|
2
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(6)
|
(5)
|
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(6)
|
(10)
|
(13)
|
(15)
|
(12)
|
(7)
|
(5)
|
(5)
|
(4)
|
(4)
|
|
| Selling, General & Administrative |
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Research & Development |
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(4)
|
(8)
|
(11)
|
(11)
|
(8)
|
(4)
|
(3)
|
(2)
|
(2)
|
(2)
|
|
| Depreciation & Amortization |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Operating Income |
(5)
N/A
|
(5)
+13%
|
(5)
+3%
|
(5)
0%
|
(4)
+16%
|
(4)
-5%
|
(4)
+6%
|
(6)
-53%
|
(10)
-68%
|
(13)
-38%
|
(15)
-13%
|
(12)
+21%
|
(7)
+44%
|
(5)
+29%
|
(5)
+5%
|
(4)
+6%
|
(4)
+14%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
1
|
(1)
|
(2)
|
(6)
|
(5)
|
0
|
(1)
|
(5)
|
(1)
|
(1)
|
(3)
|
(0)
|
(1)
|
(0)
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
3
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(3)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(5)
N/A
|
(5)
-8%
|
(7)
-31%
|
(11)
-52%
|
(9)
+20%
|
(1)
+90%
|
(5)
-462%
|
(10)
-116%
|
(11)
-8%
|
(14)
-29%
|
(18)
-25%
|
(15)
+16%
|
(8)
+44%
|
(7)
+20%
|
(6)
+6%
|
(6)
+10%
|
(5)
+20%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(5)
|
(5)
|
(7)
|
(11)
|
(9)
|
(1)
|
(5)
|
(10)
|
(11)
|
(14)
|
(18)
|
(15)
|
(8)
|
(7)
|
(6)
|
(6)
|
(5)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(5)
N/A
|
(5)
-8%
|
(7)
-31%
|
(11)
-52%
|
(9)
+19%
|
(1)
+90%
|
(5)
-462%
|
(10)
-116%
|
(11)
-8%
|
(14)
-29%
|
(18)
-25%
|
(15)
+16%
|
(8)
+44%
|
(7)
+20%
|
(6)
+6%
|
(6)
+10%
|
(5)
+20%
|
|
| EPS (Diluted) |
-248.5
N/A
|
-269.5
-8%
|
-353.5
-31%
|
-268.25
+24%
|
-86.4
+68%
|
-7.81
+91%
|
-21
-169%
|
-32.53
-55%
|
-18.42
+43%
|
-21.9
-19%
|
-20.02
+9%
|
-12.86
+36%
|
-2.51
+80%
|
-1.34
+47%
|
-0.23
+83%
|
-0.16
+30%
|
-0.04
+75%
|
|
Switch to:
Switch to:
See Also
Discover More
